Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$4.86 - $6.05 $108,693 - $135,308
-22,365 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$5.16 - $6.85 $57,580 - $76,439
-11,159 Reduced 33.29%
22,365 $139,000
Q4 2018

Feb 13, 2019

BUY
$4.89 - $7.16 $11,462 - $16,783
2,344 Added 7.52%
33,524 $170,000
Q3 2018

Nov 13, 2018

BUY
$6.89 - $7.78 $60,735 - $68,580
8,815 Added 39.41%
31,180 $225,000
Q2 2018

Aug 10, 2018

BUY
$5.19 - $7.25 $33,065 - $46,189
6,371 Added 39.83%
22,365 $149,000
Q1 2018

May 14, 2018

BUY
$3.56 - $5.74 $56,938 - $91,805
15,994 New
15,994 $88,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $331M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.